A phase 2 study of NEO-102 (ensituximab), a novel chimeric monoclonal antibody, in adult patients (pts) with unresectable, metastatic colorectal cancer (mCRC).

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. 3080-3080
Author(s):  
Richard D. Kim ◽  
Nilofer Saba Azad ◽  
Michael Morse ◽  
Benjamin R. Tan ◽  
Elizabeth Poplin ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Monoclonal Antibody ◽  
Metastatic Colorectal Cancer ◽  
Adult Patients ◽  
Phase 2 ◽  
Chimeric Monoclonal Antibody ◽  
Phase 2 Study ◽  
Unresectable Metastatic Colorectal Cancer

scholarly journals A phase 2 study of panitumumab with irinotecan as salvage therapy in chemorefractory KRAS exon 2 wild-type metastatic colorectal cancer patients

2019 ◽  
Vol 121 (5) ◽  
pp. 378-383 ◽  
Author(s):  
Elena Elez ◽  
Carles Pericay ◽  
Manuel Valladares-Ayerbes ◽  
Inmaculada Bando ◽  
Maria Jose Safont ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Cancer Patients ◽  
Salvage Therapy ◽  
Phase 2 ◽  
Wild Type ◽  
Exon 2 ◽  
Phase 2 Study ◽  
Colorectal Cancer Patients ◽  
Kras Exon

ENCORE 601: A phase 2 study of entinostat in combination with pembrolizumab in patients with microsatellite stable metastatic colorectal cancer.

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. 3557-3557 ◽  
Author(s):  
Nilofer Saba Azad ◽  
Keisuke Shirai ◽  
Autumn Jackson McRee ◽  
Mateusz Opyrchal ◽  
Douglas Buckner Johnson ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Phase 2 ◽  
Phase 2 Study

Phase 2 Study of Modified Irinotecan and Bolus 5-Fluorouracil/l-Leucovorin in Japanese Metastatic Colorectal Cancer Patients

2012 ◽  
Vol 29 (3) ◽  
pp. 287-296
Author(s):  
Eishi Baba ◽  
Hiromitsu Fujishima ◽  
Akitaka Makiyama ◽  
Keita Uchino ◽  
Risa Tanaka ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Cancer Patients ◽  
Phase 2 ◽  
Phase 2 Study ◽  
Colorectal Cancer Patients
Sign in / Sign up

Export Citation Format

Share Document